Institution
Eli Lilly (United States)
Recent research
- Health & Medicine
Abstract Amorphous solid dispersions (ASDs) are single-phase molecular mixtures of amorphous drug and polymer designed to enhance solubility, inhibit crystallization, and improve release rate, increasing bioavailability. During dissolution, water lowers the glass-transition tempe...
- Health & Medicine
OBJECTIVE: This study was conducted to describe pregnancy outcomes reported following maternal or paternal exposure to galcanezumab in clinical trials and postmarketing surveillance. BACKGROUND: Galcanezumab is a calcitonin gene-related peptide-inhibiting monoclonal antibody indi...
- Health & MedicineOpen access
Tirzepatide is a once-weekly, glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist (RA) for obesity treatment. This indirect treatment comparison (ITC) assessed the relative efficacy and safety of tirzepatide versus the GLP-1 RA semagl...
- Biology
Revealing Nanomedicine Design Principles for Efficient siRNA Delivery to the Central Nervous System
Abstract A series of polymer nanocapsules were designed and synthesized for non-viral siRNA delivery to the central nervous system via intracerebroventricular injection. Various factors can contribute to superior diffusion profiles. In this study, we find that size, charge, and m...
- Health & Medicine
Abstract Herein, we describe the development of steps 5–7 for a large-scale process to synthesize muvalaplin, a small-molecule lipoprotein(a) inhibitor for the potential reduction of major adverse cardiovascular events in participants with established cardiovascular disease or at...
- AI & ComputingOpen access
The RobinCar Family: R tools for robust covariate adjustment in randomized clinical trials
Abstract Purpose Covariate adjustment is a powerful statistical technique that can increase efficiency in clinical trials. Recent guidance from the U.S. Food and Drug Association (FDA) provided recommendations and best practices for using covariate adjustment. However, there has...
- Health & MedicineOpen access
Nociceptive pain responses are mediated by neurons in the dorsal root ganglion. Certain voltage-gated sodium channels, such as Na v 1.8, are necessary for action potential firing and sensing pain. Prior work has demonstrated that interfering with voltage-gated calcium channel act...
- Society & Economics
This study examines how well existing theoretical frameworks explain formal volunteering amid a public health crisis, focusing on dominant status, social networks, role constraints, and risk perceptions. Grounded in these four theoretical frameworks, the study tests whether the r...
- Health & MedicineOpen access
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is a major therapeutic target in type 2 diabetes and obesity. Missense variation in GIPR could confer phenotypic effects through alterations to constitutive activity or functional responses to GIP or pharmacological...
- Health & MedicineOpen access
A Review on Lymphatic Uptake of Large Therapeutic Proteins after Subcutaneous Injection
Subcutaneous (SC) administration has emerged as a promising route for delivering large therapeutic proteins, offering advantages such as improved patient convenience and reduced healthcare costs. However, the mechanisms that regulate the uptake of these macromolecules are not yet...
- BiologyOpen access
Tiny Messengers, Actionable Targets: sEV-Driven Epigenetic Changes in Cancer
Small extracellular vesicles (sEVs) are pivotal mediators of intercellular epigenetic communication in cancer. Following MISEV2023, we use the size- and isolation-based term sEV throughout, because most primary studies cited here cannot resolve which biogenetic route generated th...
- Health & MedicineOpen access
ABSTRACT The patatin‐like phospholipase 3 (PNPLA3) I148M genetic variant is highly associated with steatotic liver disease. In the SURPASS‐3 MRI substudy, tirzepatide significantly reduced liver fat content (LFC) versus insulin degludec in insulin‐naïve patients with type 2 diabe...
- Materials & EnergyOpen access
BE-BOIN: A Dose Optimization Design Accommodating Backfill and Late-Onset Toxicity
The US Food and Drug Administration (FDA) launched Project Optimus and issued guidance to reform dose-finding and selection trials, shifting the paradigm from identifying the maximum tolerated dose (MTD) to determining the optimal biological dose (OBD), which optimizes the risk a...